Sign in
4

Changes in Ownership

Arcus Biosciences, Inc. Filed Acc 0002056093-25-000005

Chief Medical Officer sold 9,546 shares at an average $22.01 ($210,144)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Markus Richard · Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-16 Sale : show line 1 in the form 10b5-1 −5,052 $21.88 $110,559 70,141 D
2025-12-17 Sale : show line 2 in the form 10b5-1 −4,494 $22.16 $99,585 65,647 D
Open-market sales · 9,546 sh · avg $22.01 · $210,144
Loading xslF345X05/wk-form4_1766097334.xml…